Publication | Open Access
Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia
61
Citations
27
References
2015
Year
D-CAG regimen was well tolerated and showed a promising clinic efficacy in elderly patients with AML (≥70 years).
| Year | Citations | |
|---|---|---|
Page 1
Page 1